Safety of Nitroglycerin for Field Treatment of STEMI

Completed

Conditions studied: Myocardial Infarction

In brief

The purpose of this study is to quantify the risk of hypotension due to field treatment with nitroglycerin in patients with ST-elevation myocardial infarction, particularly right ventricular infarcts, and secondarily to evaluate the benefit to pain relief..

Key facts

Study ID

NCT02407002

Run by

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

People needed

940

Starts

2015-06-01

Expected to finish

2017-04-30

Last updated by the study team

2017-08-25

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Identified by paramedics as having a STEMI.
• Transported to a study site.

You may not qualify if…

• Under 18 years of age
• Primary complaint of trauma
• Cardiac arrest upon EMS arrival
• Transported to a non-study site
• Transferred from another hospital
• Hypotensive on EMS arrival

Where it is running

• Cedars Sinai Medical Center — Los Angeles, California, United States
• UCLA Ronald Reagan Medical Center — Los Angeles, California, United States
• Harbor-UCLA Medical Center — Torrance, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.